Azitra, Inc. announced that the U.S. Patent and Trademark Office has issued U.S. patent No. 11,850,267 covering future potential pipeline candidates for indications including ichthyosis vulgaris, titled “Methods and compositions for treating skin disease with recombinant microorganisms.” Travis Whitfill, Azitra’s COO, co-founder, and inventor of the patent stated, “Securing this patent is crucial for expanding our pipeline.
January 16, 2024
· 4 min read